Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 4/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 6/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3421199 | 1.00 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL27983187 | 0.92 | CYP17A1 (0.51) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL29220056 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL9722522 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL18885407 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL19611321 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL28566983 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL3851254 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL28417238 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL28321826 | 0.85 | TBXAS1 (0.50) | TBXAS1CYP17A1CYP19A1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2613754-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M Innovative Properties Company (US) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012033633-A1 | CURABLE COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-15 | — | — | WO | disclosed |